Overview

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Iowa
Treatments:
Picibanil